|
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
CDK8 as a New Therapeutic Target in Alveolar Rhabdomyosarcoma |
Dana-Farber Cancer Institute |
The Maddox Potter Foundation |
|
Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out |
|
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out |
|
Stapled Oncolytic Peptides for Treatment-Resistant Pediatric Leukemias |
Dana-Farber Cancer Institute |
Cure4Cam Childhood Cancer Foundation |
|
Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies |
Boston Children’s Hospital |
Jack’s Helping Hand |
|
Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants |
University of Washington, Seattle |
The RUNX1 Research Program |
|
Families of Children with Advanced Cancer: The Impact of Social Determinants of Health |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
DEFINING GENETIC DRIVER MUTATIONS,CLINIC CHARACTERISTICS & OUTCOMES IN CHILDREN & YOUNG ADULTS WITH HISTIOCYTOSES |
Baylor College of Medicine |
Northwestern Mutual Foundation |